EUVIMEDEUVIMED entdecken
Crossref

Sex-based differences in neuropsychiatric symptoms are due to estradiol/ERα-dependent transcriptional regulation via the modulation of steroid levels by sirolimus

Makiko Koike-Kumagai, Manabu Fujimoto, Mari Wataya-Kaneda

Pharmacology Biochemistry and Behavior · 2024

DOI: 10.1016/j.pbb.2024.173875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2024. Verfasst von Makiko Koike-Kumagai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurocutaneous Medicine, Division of Health Sciences, Graduate School of Medicine, Osaka University, 2-1 Yamada-oka, Suita, Osaka 565-0…. Hauptthemen laut MEDLINE: Sirolimus, Mice, Knockout, Estradiol, Estrogen Receptor alpha. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Government of Japan Ministry of Health Labour and Welfare, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sex of the patient often affects the prevalence, progression, and severity of many psychiatric disorders. The incidence, progression, and severity of Parkinson's disease and Alzheimer's disease, the most common neurodegenerative diseases, also differ between the sexes. Sex differences in autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), and anxiety are also observed in tuberous sclerosis complex (TSC). Neuropsychiatric symptoms are one of the most important manifestations of TSC, and the multiple neuropsychiatric symptoms are collectively referred to as TSC-associated neuropsychiatric disorders (TAND). We created TSC model mice (Tsc2 conditional knockout [cKO] mice) that developed epilepsy and TAND. Sex-based differences were observed for hyperactivity and cognitive dysfunctions in Tsc2 cKO mice with TAND, indicating more severe symptoms in female mice than in male mice. TSC is thought to be caused by the hyperactivation of mechanistic target of rapamycin complex 1 (mTORC1), and mTORC1 inhibitors improve almost all TSC symptoms. Treatment with sirolimus, an mTORC1 inhibitor, improved TAND in Tsc2 cKO mice. We aimed to elucidate the mechanism underlying sex-based differences in TAND using Tsc2 cKO mice and sirolimus. We found that estradiol (E2) and estrogen receptor (ER)α are involved in sex differences in neuropsychiatric symptoms, and discovered a novel function of sirolimus. We showed that sirolimus ameliorated TAND by modulating brain steroid levels and regulating E2/ERα-dependent transcriptional activation. This indicates sirolimus may be beneficial for the treatment of TAND as well as diseases caused by sex-based differences and steroid levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SirolimusMice, KnockoutEstradiolEstrogen Receptor alphaSex CharacteristicsTuberous Sclerosis Complex 2 ProteinAnimalsFemaleMaleMiceTuberous SclerosisMechanistic Target of Rapamycin Complex 1Mental DisordersMice, Inbred C57BLDisease Models, AnimalTranscription, Genetic

Stichwörter der Autor:innen

Estradiol (E2)Estrogen receptor (ER)ProgesteroneSirolimusTSC-associated neuropsychiatric disorders (TAND)Tuberous sclerosis complex (TSC)

Substanzen

SirolimusEstradiolEstrogen Receptor alphaTuberous Sclerosis Complex 2 ProteinTsc2 protein, mouseEsr1 protein, mouseMechanistic Target of Rapamycin Complex 1

Autor:innen und Institutionen

  • Department of Neurocutaneous Medicine, Division of Health Sciences, Graduate School of Medicine, Osaka University, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan. Electronic address: mkumagai@sahs.med.osaka-u.ac.jp.
  • Department of Dermatology, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan. Electronic address: fujimoto@derma.med.osaka-u.ac.jp.
  • Department of Neurocutaneous Medicine, Division of Health Sciences, Graduate School of Medicine, Osaka University, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan. Electronic address: mkaneda@sahs.med.osaka-u.ac.jp.

Förderung

  • Japan Agency for Medical Research and Development
  • Government of Japan Ministry of Health Labour and Welfare
  • Japan Society for the Promotion of Science

Zitieren

APA

Koike-Kumagai, M., Fujimoto, M., & Wataya-Kaneda, M. (2024). Sex-based differences in neuropsychiatric symptoms are due to estradiol/ERα-dependent transcriptional regulation via the modulation of steroid levels by sirolimus. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2024.173875

Vancouver

Koike-Kumagai M, Fujimoto M, Wataya-Kaneda M. Sex-based differences in neuropsychiatric symptoms are due to estradiol/ERα-dependent transcriptional regulation via the modulation of steroid levels by sirolimus. Pharmacology Biochemistry and Behavior. 2024. doi:10.1016/j.pbb.2024.173875

BibTeX
@article{KoikeKumagai2024,
  author = {Koike-Kumagai, Makiko and Fujimoto, Manabu and Wataya-Kaneda, Mari},
  title = {Sex-based differences in neuropsychiatric symptoms are due to estradiol/ERα-dependent transcriptional regulation via the modulation of steroid levels by sirolimus},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2024},
  doi = {10.1016/j.pbb.2024.173875}
}
Kostenlos starten →